Cost-effectiveness analysis of the impacts on infection and morbidity attributable to three chemotherapy schemes against Schistosoma Japonicum in hyperendemic areas of the Dongting lake region, China

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 33, Issue 3, 2002, Pages 441-457

  Yu, Dongbao ^a,d   Sarol Jr , Jesus N ^b   Hutton, Guy ^c   Tan, Dunli ^a   Tanner, Marcel ^c  

^a HUNAN INSTITUTE OF PARASITIC DISEASES   (China)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; PRAZIQUANTEL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHINA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; ENDEMIC DISEASE; FEMALE; HEALTH CARE COST; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; PATIENT SELECTION; PRESCHOOL CHILD; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SCHISTOSOMA JAPONICUM;

ADOLESCENT; ADULT; AGED; ANTHELMINTICS; CHILD; CHILD, PRESCHOOL; CHINA; CLINICAL PROTOCOLS; COST-BENEFIT ANALYSIS; ENDEMIC DISEASES; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; PRAZIQUANTEL; PREVALENCE; SCHISTOSOMIASIS JAPONICA;

EID: 0037812514     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Anonymous. Forty years of Fighting against endemic diseases in China. Beijing: Environmental Science Publishing House, China 1990 (in Chinese).
2. Booth M, Guyatt H, Li YS, et al. The morbidity attributable to Schistosoma japonicum infection in 3 villages in Dongting Lake region. Hunan Province, PR China. Trop Med Int Health 1996; 1: 646-54.
3. Butterworth AE, Dunne DW, Fulford AJC, et al. Immunity and morbidity in Schistosoma mansoni infection: Quantitative aspects. Am J Trop Med Hyg 1996; 55: 109-15.
4. Chen Y, Xie MS, Wang FH, et al. A sampling survey on schistosomiasis in Hunan Province in 1995. In: China: A nation-wide Sampling Survey on Schistosomiasis in 1995. Nanjing University Press, 1998: 18-26
5. Creese A. Parker D. Cost analysis in primary health care. Geneva: World Health Organization, 1994.
6. Doenhoff MJ, Kimani G, Cioli D. Praziquantel and the control of schistosomiasis. Parasitol Today 2000; 16: 364-6.
7. Gryseels B. Uncertainties in the epidemiology and control of schistosomiasis. Am J Trop Med Hyg 1996: 55: 103-8.
8. Guyatt HL, Tanner M. Different approaches to modelling the cost effectiveness of schistosomiasis control. Am J Trop Med Hyg 1996: 55: 159-64.
9. Hagan P. Immunity and morbidity in infection due to Schistosoma haematobium. Am J Trop Med Hyg 1996; 55: 116-20.
10. Jiang SD, Li XC. Huang FP, et al. Study on cost-effectiveness of clue chemotherapy in hyper-endemic areas of schistosomiasis. Joint Research Management Committee (JRMC) Project Report, Proceeding of JRMC Summary Meeting in Wuhan, China, 1999 (in Chinese).
11. Li YS, Ross AGP, Yu DB, et al. An evaluation of Schistosoma japonicum infections in three villages in the Dongting Lake region of China. I. Prevalence, intensity and morbidity before implementation of adequate control strategies. Acta Tropica 1997; 68: 77-91.
12. Liang YS, Dai JR, Ning A, et al. Susceptibility of Schistosoma japonicum to praziquantel in China. Trop Med Int Health 2001; 6: 707-14.
13. Lin DD, Jiang QW, Liu YM, et al. Cost-effectiveness analysis of different chemotherapy strategies against schistosomiasis in Poyang Lake region. In: Zheng QS, Zheng J, eds. Social medicine and schistosomiasis. Tianjin: Tianjin Science and Technology Press 2000: 191-4 (in Chinese).
14. Liu BZ, Wei JB, Wang FH, et al. Cost-effectiveness analysis of different control strategies against schistosomiasis. In: Zheng QS, Zheng J, eds. Social medicine and schistosomiasis. Tianjin, Tianjin Science and Technology Press 2000: 188-90 (in Chinese).
15. Olds GR, Olvelda R, Wu GL, et al. Immunity and morbidity in Schistosoma japonicum infection. Am J Trop Med Hyg 1996; 55: 121-6.
16. Qiu ZL, Wu X, Chen JX, et al. Cost-effectiveness analysis of optimized strategies for schistosomiasis control. In: Zheng QS, Zheng J. eds. Social medicine and schistosomiasis. Tianjin: Tianjin Science and Technology Press 2000: 181-3 (in Chinese).
17. Ross AGP, Li YS, Booth M, et al. Five year impact of chemotherapy on morbidity attributable to Schistosoma japonicum infection in the Dongting Lake region. Trop Med Int Health 1998; 3: 837-41.
18. Ross AGP, Li YS, Sleigh AS, et al. Schistosomiasis control in the People's Republic of China. Parasitol Today 1997; 13: 152-5.
19. th ed. Boston: Little, Brown and Company, 1986.
20. TDR/WHO. Meeting on ultrasonography in schistosomiasis, proposal for practical guide to the standardized use of ultrasound in the assessment of pathological changes. Annex C: S. japonicum investigation. Geneva: TDR/SCH/ULTRASON/ 91.3, 1993.
21. Tian WQ. Compilation of maps and materials on schistosomiasis. Changsha, Hunan Map Publishing House, 1990 (in Chinese).
22. Vennervald BJ, Ouma JH, Butterworth AE. Morbidity in schistosomiasis: assessment, mechanisms and control. Parasitol Today 1998; 14: 385-90.
23. Wen S, Gu XG, Xu FC, et al. Economic benefit from schistosomiasis control in mountainous region. In: Zheng QS, Zheng J, eds. Social medicine and schistosomiasis. Tianjin: Tianjin Science and Technology Press 2000: 177-80 (in Chinese).
24. WHO.http://www.who.int/ctd/schisto/dates.htm, 2000.
25. WHO. The control of schistosomiasis: second report of the WHO Expert Committee. Geneva: World Health Organization, 1993.
26. Wu ZW, Bu KM, Yuan LP, et al. Factors contributing to reinfection with schistosomiasis japonica after treatment in the lake region of China. Acta Tropica 1993; 54: 83-8.
27. Yu DB, Li Y, Sleigh AC, et al. Efficacy of praziquantel against Schistosoma japonicum: field evaluation in an area with repeated chemotherapy compared with a newly-identified endemic focus in Hunan, China. Trans R Soc Trop Med Hyg 2001; 95.
28. Yu DB, Ross AGP, Xie MS, et al. Highlights on the World Bank loan schistosomiasis control program in China (1991-1998): A special focus on Hunan Province. Southeast Asian J Trop Med Public Health 1999, 30: 657-63.
29. Yun ZC, Tan GP, Dai XB, et al. The commonly used control strategies and their costs for schistosomiasis control in mountainous region. In: Zheng QS, Zheng J, eds. Social Medicine and Schistosomiasis. Tianjin: Tianjin Science and Technology Press 2000: 184-7 (in Chinese).
30. Zheng QS, Feng P. Social medicine and schistosomiasis. In: Zheng QS, Zheng J, eds. Social medicine and schistosomiasis. Tianjin: Tianjin Science and Technology Press, 2000: 1-3.
31. Zhou A, Guo LM. Ultrasonography technology. Beijing: People's Health Press, 1998.
32. Zhou DR, Li YS, Yang XM. Schistosomiasis control in China. World Health Forum 1994; 15: 387-9.